MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targetingSilvia Pomella, Rossella Rota, Matteo Cassandri et al.|Nature Communications|2023Cited by 24